Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia
Public ClinicalTrials.gov record NCT03160521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Study identification
- NCT ID
- NCT03160521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Rovi Pharmaceuticals Laboratories
- Industry
- Enrollment
- 438 participants
Conditions and interventions
Conditions
Interventions
- Risperidone ISM 75 mg Drug
- Risperidone ISM 100 mg Drug
- Placebo of Risperidone ISM Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1, 2017
- Primary completion
- Dec 16, 2018
- Completion
- Dec 16, 2018
- Last update posted
- Feb 21, 2022
2017 – 2018
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland Research Northwest | Rogers | Arkansas | 72758 | — |
| CIMU Bellflower | Cerritos | California | 90703 | — |
| Collaborative Neuroscience Network, LLC. | Garden Grove | California | 92845 | — |
| Synergy Research San Diego | Lemon Grove | California | 91945 | — |
| Apostle Clinical Trials | Long Beach | California | 90813 | — |
| NRC Research Institute | Orange | California | 92868 | — |
| CNRI-Los Angeles LLC | Pico Rivera | California | 90660 | — |
| CNRI-San Diego | San Diego | California | 92112 | — |
| Galiz Research | Hialeah | Florida | 33016 | — |
| Innovative Clinical Research Inc. | Hollywood | Florida | 33021 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| CBH Health LLC | Gaithersburg | Maryland | 20877 | — |
| Precise Research Centers MS | Flowood | Mississippi | 39232 | — |
| Altea Research Institute | Las Vegas | Nevada | 89102 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| Carolina Clinical Triasl Inc | Charleston | South Carolina | 29407 | — |
| Community Clinical Research Inc. | Austin | Texas | 78754 | — |
| InSite Clinical Research | DeSoto | Texas | 75115 | — |
| Pillar Clinical Research LLC | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03160521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03160521 live on ClinicalTrials.gov.